FEP+ Protocol Builder

ML-powered optimization of FEP+ models for challenging targets

FEP+ Protocol Builder

FEP+ Protocol Builder is an automated machine learning workflow for FEP+ model optimization. It saves scientists time and improves the chances of successfully enabling discovery with FEP+ by identifying an optimized predictive model for your target.

Improve FEP+ accuracy with physics-driven machine learning for the most challenging targets to confidently use FEP+ prospectively in your program

Reduce compute cost across the lifetime of your project with automated cost optimization of FEP+ models

Generate optimized FEP+ models 4x faster than manual optimization, saving weeks of researcher time across diverse disease areas through efficient exploration of parameter space

Expedite FEP+ use for challenging systems with a fully automated workflow

Fully automated FEP+ Protocol Builder generated optimized FEP+ protocol with improved pairwise RMSE compared to default model. All protocols were performed with the same 15 congeneric ligands with modifications at 2 R-groups with known affinity data from PDB ID: 2IVV. FEP+ Protocol Builder was applied to quickly and rigorously validate the amenability of the target to the Schrödinger platform.

Workflow Description Library Size Time to screen 4.0B (days) Time to screen 6.5B (days) Storage space for 6.5B (TB)
Quick Shape Combination of 1D-SIM* prefilter and Shape CPU Screening > 4.0 billion 5.2 5.5‡ 0.4
Shape GPU GPU-accelerated 3D screening < 5.0 billion 4.6 7.5‡ 33
Shape CPU CPU-based 3D screening < 10 million NA NA NA

FEP+ Protocol Builder models routinely outperform those from human experts across diverse protein targets

In a recent study, FEP+ Protocol Builder outperformed human experts in producing a predictive model across ten diverse targets where default FEP+ settings did not produce an appropriately accurate protocol (RMSE > 2.5 kcal/mol) and were able to generate FEP+ models for systems where experts failed.

FEP+ Protocol Builder was run in a completely automated fashion following a rigorous training/test set split. On average, the reduction in turnaround time for the final optimization model went from 27 days to 7 days, a 4x acceleration, saving on average 20 days per project.

Disease area Target class Target Expert Protocol RMSE (kcal/mol) Expert Protocol RMSE (kcal/mol)
Oncology Bcl-2 MCL1 1.5

1.1

Neurology ATPase P97 1.3

1.0

Oncology Nuclear receptor ESR1 3.1

2.0

Pain, addiction, oncology GPCR mOR 2.4

2.2

Pain, addiction GPCR dOR 2.2

1.3

Hematology, oncology ADP-ribosyltransferase TNKS2 2.2

1.1

Pain, addiction, neurology GPCR KOR 2.1

1.7

Renal Aspartic protease Renin 1.8

1.6

Oncology and rheumatology Cysteine protease MALT1 2.5

1.5

Oncology Receptor tyrosine kinase RET 1.9

0.8

Webinar

Expediting FEP+ model optimization for challenging systems with a fully automated, machine learning-driven workflow

FEP+ is a powerful predictive technology in drug discovery – with applications from hit discovery through lead optimization. A critical first step in deploying FEP+ is to validate and optimize the model for the protein-ligand system of interest.

Watch Webinar

Machine learning driven FEP+ Protocol Builder workflow

Recommended inputs
  • One experimentally resolved protein-ligand structure or a computationally generated protein-ligand binding mode hypothesis
  • 10 or more congeneric ligands, ideally 20 for better statistics, are needed. The ligands should have known affinity data spanning at least two to three orders of magnitude
  • FEP+ Protocol Builder is bundled with FEP+ and requires a minimum of 20 licenses for optimal use
Available as software or a service
  • Leverage your internal resources or work with Schrödinger’s team of experts and large-scale computational resources to optimize your next FEP+ model.

Publications

  1. FEP+ Protocol Builder: Optimization of free energy perturbation protocols using active learning

    de Oliveira C, et al. J. Chem. Inf. Model. 2023, 63, 17, 5592–5603.

  2. Advancing drug discovery through enhanced free energy calculations

    Abel R, et al. Acc. Chem. Res. 2017, 50, 7, 1625–1632.

  3. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field

    Abel R, et al. J. Am. Chem. Soc. 2015, 137, 7, 2695–2703.